Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 in Patients with Invasive Fungal Infections that are Refractory to or Intolerant of Standard Antifungal Treatment (FURII)

Administered By

Awarded By

Contributors

Start/End

  • November 29, 2016 - April 30, 2020